San Francisco, CA, United States of America

Aaron DeLoughery

This inventor holds 2 USPTO granted patents and 20 published patent applications. Top assignee: Mammoth Biosciences, Inc.. Active years: 2023-2024.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.6

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Aaron DeLoughery

Introduction

Aaron DeLoughery is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of effector proteins and their applications. With a total of two patents to his name, DeLoughery is recognized for his innovative work in genetic engineering.

Latest Patents

DeLoughery's latest patents focus on effector proteins and methods of use. These patents describe compositions, systems, and methods that utilize effector proteins, which are shown to be active with guide RNAs and characterized as CRISPR-associated (Cas) proteins. The innovations leverage the activities of these effector proteins for the modification, detection, and engineering of nucleic acids, showcasing their potential in various biotechnological applications.

Career Highlights

Aaron DeLoughery is currently employed at Mammoth Biosciences, Inc., where he continues to push the boundaries of genetic research. His work at the company emphasizes the practical applications of his inventions in the biotechnology sector.

Collaborations

DeLoughery collaborates with notable colleagues, including Lucas Benjamin Harrington and Wiputra Jaya Hartono. These partnerships enhance the innovative environment at Mammoth Biosciences, fostering advancements in their research initiatives.

Conclusion

Aaron DeLoughery's contributions to biotechnology through his patents and work at Mammoth Biosciences highlight his role as a leading inventor in the field. His focus on effector proteins and their applications demonstrates the potential for significant advancements in genetic engineering.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…